AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESR2 | Estrogen receptor 2 (ER beta) | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ESRRG | Estrogen-related receptor gamma | FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR3C2 | Nuclear receptor subfamily 3, group C, member 2 | Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Group enriched |
PPARA | Peroxisome proliferator-activated receptor alpha | FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
PPARD | Peroxisome proliferator-activated receptor delta | FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
PPARG | Peroxisome proliferator-activated receptor gamma | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RARA | Retinoic acid receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
RXRA | Retinoid X receptor, alpha | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
RXRB | Retinoid X receptor, beta | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
RXRG | Retinoid X receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enriched |
THRA | Thyroid hormone receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Expressed in all |
THRB | Thyroid hormone receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |